Osteoporosis is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

CLINICAL

  • Osteoporosis in HIV+ pts 3-4x more common than in general population.
  • Increased prevalence may be due in part to high prevalence of risk factors, including low body weight, hypogonadism, smoking, alcohol use, steroid use.
  • Role of ART unclear. ART initiation associated with 2-3% loss in bone mineral density (BMD) in first 6 mos in multiple studies. Unclear if due to medication effect or by-product of viral suppression and/or immune reconstitution. Longitudinal studies of treated HIV+ pts generally show stable BMD over time.
  • Specific ARVs not clearly implicated in pathogenesis, although bone loss with TDF slightly more pronounced than with d4T.
  • BMD explains approximately 50% of fracture risk in general population,perhaps less in HIV+ pts. Bone quality also important but difficult to assess.
  • Fracture risk in HIV+ pts not adequately assessed to date

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: February 2, 2011